Form 8-K - Current report:
SEC Accession No. 0001437749-24-030380
Filing Date
2024-10-01
Accepted
2024-10-01 17:29:07
Documents
15
Period of Report
2024-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20241001_8k.htm   iXBRL 8-K 23831
2 EXHIBIT 10.1 ex_728872.htm EX-10.1 21074
  Complete submission text file 0001437749-24-030380.txt   181675

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlph-20240930.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20240930_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20240930_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20240930_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT acrx20241001_8k_htm.xml XML 2827
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 241344523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)